Skip to main content
Erschienen in: World Journal of Urology 12/2016

30.03.2016 | Original Article

Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms

verfasst von: Sulabha Argade, Zoltan Berecz, Yongxuan Su, C. Lowell Parsons

Erschienen in: World Journal of Urology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify and quantify toxic urinary cations in male patients with bladder pain syndrome/interstitial cystitis versus male controls, to compare them in symptomatic patients to those significantly improved, and to evaluate cytotoxicity of these cations to cultured urothelial cells to determine whether Tamm-Horsfall protein (THP) can neutralize the cations.

Methods

Isolation of cationic fraction (CFs) was achieved by solid phase extraction on urine specimens of 51 male patients with IC and 33 male controls. C18 reverse-phase high-performance liquid chromatography was used to profile and quantify cationic metabolites. Major CF peaks were identified by liquid chromatography–tandem mass spectrometry. HTB-4 urothelial cells were used to determine the cytotoxicity of CFs, individual metabolites, and of metabolite mixture with THP of patient versus THP of control subject.

Results

CF content was significantly higher in patients compared to controls (p < 0.001). Patients had higher levels of modified nucleosides, amino acids, and their derivatives compared to controls. Cytotoxicity for control versus patient mean (SEM) percent was 1.7 (2.9) % versus 63.0 (3.7) %, respectively, (p < 0.001). Cytotoxicity of metabolites was reduced in the presence of THP of control compared to THP of patient (p < 0.001).

Conclusions

Patients with IC had significantly higher levels of cationic metabolites with higher cytotoxicity compared to controls. THP of these patients had reduced ability to sequester cytotoxicity of cationic metabolites. Patients who significantly improved on therapy had the same levels and toxicity of cationic metabolites as symptomatic males, suggesting that these cations may be the cause of epithelial dysfunction in IC.
Literatur
1.
Zurück zum Zitat Parsons CL, Albo M (2002) Intravesical potassium sensitivity in patients with prostatitis. J Urol 168:1054–1057CrossRefPubMed Parsons CL, Albo M (2002) Intravesical potassium sensitivity in patients with prostatitis. J Urol 168:1054–1057CrossRefPubMed
2.
Zurück zum Zitat Hassan AA, Elgamal SA, Sabaa MA et al (2007) Evaluation of intravesical potassium sensitivity test and bladder biopsy in patients with chronic prostatitis/chronic pelvic pain syndrome. Int J Urol 14:738–742CrossRefPubMed Hassan AA, Elgamal SA, Sabaa MA et al (2007) Evaluation of intravesical potassium sensitivity test and bladder biopsy in patients with chronic prostatitis/chronic pelvic pain syndrome. Int J Urol 14:738–742CrossRefPubMed
4.
Zurück zum Zitat Parsons CL, Boychuk D, Jones S et al (1990) Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139–142PubMed Parsons CL, Boychuk D, Jones S et al (1990) Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143:139–142PubMed
5.
Zurück zum Zitat Lilly JD, Parsons CL (1990) Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 171:493–496PubMed Lilly JD, Parsons CL (1990) Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet 171:493–496PubMed
6.
Zurück zum Zitat Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145:732–735PubMed Parsons CL, Lilly JD, Stein P (1991) Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145:732–735PubMed
7.
Zurück zum Zitat Parsons CL, Greenberger M, Gabal L et al (1998) The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 159:1862–1866 (discussion 1866–1867) CrossRefPubMed Parsons CL, Greenberger M, Gabal L et al (1998) The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 159:1862–1866 (discussion 1866–1867) CrossRefPubMed
8.
Zurück zum Zitat Parsons CL, Stein PC, Bidair M et al (1994) Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13:515–520CrossRefPubMed Parsons CL, Stein PC, Bidair M et al (1994) Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13:515–520CrossRefPubMed
13.
Zurück zum Zitat Kushner L, Chiu PY, Brettschneider N et al (2001) Urinary substance P concentration correlates with urinary frequency and urgency in interstitial cystitis patients treated with intravesical dimethyl sulfoxide and not intravesical anesthetic cocktail. Urology 57:129CrossRefPubMed Kushner L, Chiu PY, Brettschneider N et al (2001) Urinary substance P concentration correlates with urinary frequency and urgency in interstitial cystitis patients treated with intravesical dimethyl sulfoxide and not intravesical anesthetic cocktail. Urology 57:129CrossRefPubMed
14.
Zurück zum Zitat Keay S, Zhang CO, Trifillis AL et al (1996) Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 156:2073–2078CrossRefPubMed Keay S, Zhang CO, Trifillis AL et al (1996) Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 156:2073–2078CrossRefPubMed
15.
Zurück zum Zitat Keay S, Reeder JE, Koch K et al (2007) Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG). World J Urol 25:499–504CrossRefPubMed Keay S, Reeder JE, Koch K et al (2007) Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG). World J Urol 25:499–504CrossRefPubMed
16.
Zurück zum Zitat Parsons CL, Bautista SL, Stein PC et al (2000) Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J Urol 164:1381–1384CrossRefPubMed Parsons CL, Bautista SL, Stein PC et al (2000) Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J Urol 164:1381–1384CrossRefPubMed
17.
Zurück zum Zitat Parsons CL, Rajasekaran M, Arsanjani AH et al (2007) Role of sialic acid in urinary cytoprotective activity of Tamm-Horsfall protein. Urology 69:577–581CrossRefPubMed Parsons CL, Rajasekaran M, Arsanjani AH et al (2007) Role of sialic acid in urinary cytoprotective activity of Tamm-Horsfall protein. Urology 69:577–581CrossRefPubMed
18.
Zurück zum Zitat Stein P, Rajasekaran M, Parsons CL (2005) Tamm-Horsfall protein protects urothelial permeability barrier. Urology 66:903–907CrossRefPubMed Stein P, Rajasekaran M, Parsons CL (2005) Tamm-Horsfall protein protects urothelial permeability barrier. Urology 66:903–907CrossRefPubMed
19.
Zurück zum Zitat Rajasekaran M, Stein P, Parsons CL (2006) Toxic factors in human urine that injure urothelium. Int J Urol 13:409–414CrossRefPubMed Rajasekaran M, Stein P, Parsons CL (2006) Toxic factors in human urine that injure urothelium. Int J Urol 13:409–414CrossRefPubMed
21.
Zurück zum Zitat Parsons CL, Dell J, Stanford EJ et al (2002) Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 60:573–578CrossRefPubMed Parsons CL, Dell J, Stanford EJ et al (2002) Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 60:573–578CrossRefPubMed
22.
Zurück zum Zitat Gillenwater JY, Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 140:203–206PubMed Gillenwater JY, Wein AJ (1988) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol 140:203–206PubMed
24.
Zurück zum Zitat Parsons CL, Benson G, Childs SJ et al (1993) A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 150:845–848PubMed Parsons CL, Benson G, Childs SJ et al (1993) A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 150:845–848PubMed
25.
Zurück zum Zitat Gillespie L (1993) Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms. Br J Urol 72:293–297CrossRefPubMed Gillespie L (1993) Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms. Br J Urol 72:293–297CrossRefPubMed
26.
Zurück zum Zitat Kaufman JE, Anderson K, Parsons CL (1987) Inactivation of antiadherence effect of bladder surface glycosaminoglycans as possible mechanism for carcinogenesis. Urology 30:255–258CrossRefPubMed Kaufman JE, Anderson K, Parsons CL (1987) Inactivation of antiadherence effect of bladder surface glycosaminoglycans as possible mechanism for carcinogenesis. Urology 30:255–258CrossRefPubMed
27.
Zurück zum Zitat Akiyama A, Stein PC, Houshiar A et al (2000) Urothelial cytoprotective activity of Tamm-Horsfall protein isolated from the urine of healthy subjects and patients with interstitial cystitis. Int J Urol 7:176–183CrossRefPubMed Akiyama A, Stein PC, Houshiar A et al (2000) Urothelial cytoprotective activity of Tamm-Horsfall protein isolated from the urine of healthy subjects and patients with interstitial cystitis. Int J Urol 7:176–183CrossRefPubMed
29.
Zurück zum Zitat Parsons CL, Stein P, Zupkas P et al (2007) Defective Tamm-Horsfall protein in patients with interstitial cystitis. J Urol 178:2665–2670CrossRefPubMed Parsons CL, Stein P, Zupkas P et al (2007) Defective Tamm-Horsfall protein in patients with interstitial cystitis. J Urol 178:2665–2670CrossRefPubMed
Metadaten
Titel
Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms
verfasst von
Sulabha Argade
Zoltan Berecz
Yongxuan Su
C. Lowell Parsons
Publikationsdatum
30.03.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 12/2016
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-016-1808-4

Weitere Artikel der Ausgabe 12/2016

World Journal of Urology 12/2016 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.